ESCO Reports Fourth Quarter and Fiscal 2026 Results
ESCO delivers record sales, earnings, and backlog, with strong guidance for 2027 growth.
What the company is saying
ESCO Technologies Inc. reports a year of record financial and operational performance, highlighting a 21% increase in FY 2026 sales to $1.3 billion and a 40% rise in Adjusted EPS to $8.42. The company emphasizes both organic growth and the successful integration of acquisitions, notably ESCO Maritime Solutions and the recently closed Megger transaction. CEO Bryan Sayler attributes these results to operational improvements, employee execution, and price increases, while noting inflationary and mix pressures. The narrative is confident, focusing on durable long-term growth drivers, a record $1.5 billion backlog, and robust order momentum across all segments. Guidance for FY 2027 projects consolidated sales growth of 55–58% and Adjusted EPS of $9.40–$9.70, with detailed segment expectations and margin targets. The company also discloses a quarterly dividend and upcoming annual meeting, reinforcing a message of stability and continued shareholder returns.
What the data suggests
The disclosed figures show broad-based financial improvement: FY 2026 sales rose $227 million (21%) to $1.3 billion, with $106 million (10%) organic growth and $121 million (11%) from the Maritime acquisition. GAAP EPS from continuing operations increased 25% to $5.63, and Adjusted EPS surged 40% to $8.42. Net cash from operating activities grew by $95 million to $296 million. Orders and backlog reached new highs, with FY 2026 entered orders up $172 million (11%) to $1.7 billion and backlog at $1.5 billion. Segment data confirm strong performance in Aerospace & Defense (sales up 36% to $652.5 million, Adjusted EBIT up $58.4 million to $188.1 million), solid growth in RF Test & Measurement, and modest gains in Utility Solutions Group despite NRG weakness. The Megger acquisition, closed October 1, 2026, is expected to drive a 170–175% increase in USG sales for FY 2027. Forward guidance is specific, with sales, margin, and EPS targets all quantified. Management attributes gains to higher volume, price increases, and successful integration, while acknowledging inflation and product mix as partial offsets. The data is detailed, segment-specific, and supports the company’s positive outlook.
Analysis
The announcement provides a detailed and transparent account of realised financial and operational progress for FY and Q4 2026, including sales, EPS, EBIT, cash flow, and order/backlog growth, all supported by specific numerical disclosures. Forward-looking statements regarding FY 2027 are clearly separated from realised results and are presented as guidance, not as accomplished facts. The tone is positive but proportionate to the strong, broad-based improvements across key profitability and cash flow metrics. There is no evidence of narrative inflation or overstatement: the language is factual, and the realised results are substantial. The only minor gap is the lack of explicit Q4 2026 organic/inorganic sales split, but this does not materially affect the overall signal. No large capital outlay is paired with only long-dated, uncertain returns; the Megger acquisition is already closed and integration is underway.
Risk flags
- ●Integration risk from the Megger acquisition is material: while integration planning began before closing, actual execution of cost reduction and operational alignment is ongoing and could face unforeseen challenges, potentially impacting projected USG growth and margins.
- ●Inflationary pressures and product mix shifts are cited as partial offsets to margin gains in several segments, suggesting that future profitability could be affected if cost inflation accelerates or if less profitable product lines grow faster than expected.
- ●USG segment shows underlying weakness in NRG, with FY 2026 NRG sales down 27% and orders down 20%, partially offsetting Doble’s strength; if renewables markets or tax credits remain weak, this could drag on segment results.
- ●Aerospace & Defense and Test segments are exposed to government and military project cycles; delays in contract awards, appropriations, or geopolitical disruptions (including those involving Iran and Lebanon) could affect order flow and revenue timing.
- ●Forward-looking guidance assumes continued strong demand and successful integration; any shortfall in execution, macroeconomic deterioration, or supply chain disruption could cause the company to miss its ambitious FY 2027 targets.
Bottom line
ESCO Technologies posts a year of record sales, earnings, and cash flow, driven by both organic growth and the Maritime acquisition, with the Megger deal set to further boost results in FY 2027. The company’s detailed disclosures and segment-level data support management’s confident outlook, though execution on Megger integration and inflation management will be critical. The order book and backlog provide strong near-term visibility, but risks remain around acquisition integration, renewables market softness, and exposure to government project cycles. Investors should focus on progress with Megger integration, margin trends, and whether USG’s NRG unit stabilizes. The most important takeaway is that ESCO is entering FY 2027 with momentum, but delivery on ambitious guidance will be the key test.
Announcement summary
(NYSE:ESE) ESCO Technologies Inc. reported its operating results for the fourth quarter and fiscal year ended September 30, 2026. Q4 2026 sales increased $31 million (9 percent) to $384 million compared to $353 million in Q4 2025, with all growth being organic. FY 2026 sales increased $227 million (21 percent) to $1.3 billion compared to $1.1 billion in FY 2025, with $106 million (10 percent) organic growth and $121 million (11 percent) inorganic growth from the Maritime acquisition. Q4 2026 GAAP EPS from Continuing Operations rose 14 percent to $1.97 per share, and Adjusted EPS increased 15 percent to $2.67 per share. FY 2026 GAAP EPS from Continuing Operations increased 25 percent to $5.63 per share, and Adjusted EPS rose 40 percent to $8.42 per share. Q4 2026 entered orders increased $71 million (22 percent) to $392 million, with a book-to-bill of 1.02x. FY 2026 entered orders increased $172 million (11 percent) to $1.7 billion, resulting in a record year-end backlog of $1.5 billion; organic orders increased $232 million (20 percent). Net cash provided by operating activities from continuing operations was $102 million in Q4 2026 and $296 million for FY 2026, an increase of $95 million over FY 2025. In Aerospace & Defense, Q4 2026 sales increased $19.8 million (12 percent) to $190.2 million, and FY 2026 sales increased $174.3 million (36 percent) to $652.5 million, with $53.2 million organic growth and $121.1 million from Maritime. Q4 2026 A&D EBIT increased $9.5 million to $56.4 million, and Adjusted EBIT increased $7.7 million to $56.4 million (29.7 percent margin). FY 2026 A&D EBIT increased $62.6 million to $187.7 million, and Adjusted EBIT increased $58.4 million to $188.1 million (28.8 percent margin). Q4 2026 A&D entered orders increased $51.7 million (36 percent) to $193.6 million, and FY 2026 entered orders increased $59.8 million (7 percent) to $955.4 million, with a record year-end backlog of $1.1 billion and organic orders up $119.4 million (24.8 percent). In Utility Solutions Group, Q4 2026 sales increased $3.8 million (3 percent) to $114.0 million, with Doble sales up $7.2 million (8 percent) and NRG sales down $3.4 million (20 percent). FY 2026 USG sales increased $15.0 million (4 percent) to $395.0 million, with Doble up $32.7 million (10 percent) and NRG down $17.7 million (27 percent). Q4 2026 USG EBIT decreased $0.7 million to $31.2 million, and Adjusted EBIT decreased $0.6 million to $31.4 million (27.5 percent margin). FY 2026 USG EBIT increased $0.5 million to $95.2 million, and Adjusted EBIT increased $1.1 million to $96.3 million (24.4 percent margin). Q4 2026 USG entered orders increased $11.8 million (10 percent) to $128.0 million, with Doble orders up $11.6 million (11 percent) and NRG orders up $0.2 million (1 percent). FY 2026 USG entered orders increased $51.4 million (13 percent) to $454.9 million, with Doble up $64.3 million (19 percent) and NRG down $12.9 million (20 percent), resulting in a year-end backlog of $203.4 million. In RF Test & Measurement, Q4 2026 sales increased $7.7 million (11 percent) to $79.8 million, and FY 2026 sales increased $37.3 million (16 percent) to $274.5 million. Q4 2026 Test EBIT increased $0.6 million to $13.2 million, and Adjusted EBIT increased $1.3 million to $13.9 million (17.5 percent margin). FY 2026 Test EBIT increased $6.8 million to $40.9 million, and Adjusted EBIT increased $9.1 million to $43.7 million (15.9 percent margin). Q4 2026 Test entered orders increased $7.9 million (13 percent) to $70.7 million. FY 2026 Test entered orders increased $61.2 million (23 percent) to $326.9 million, resulting in a record year-end backlog of $239.6 million. The Megger transaction closed on October 1, 2026, with integration and cost reduction initiatives underway. For FY 2027, net sales are expected to grow 55 to 58 percent to $2.05 to $2.09 billion, with A&D up 7 to 9 percent, USG up 170 to 175 percent (including Megger revenue of $640 to $660 million), and Test up 5 to 7 percent. Adjusted EBIT is expected to increase 51 to 55 percent with margins of 21.2 to 21.8 percent, and Adjusted EBITDA is expected to increase 53 to 57 percent with margins of 24.2 to 24.8 percent. Interest is expected to be $61 to $63 million, and the effective income tax rate is expected to be 22.5 percent. FY 2027 Adjusted EPS is expected to increase 12 to 15 percent to $9.40 to $9.70 per share, and Q1 2027 Adjusted EPS is expected to increase 13 to 19 percent to $1.85 - $1.95 per share. The next quarterly cash dividend of $0.08 per share will be paid on January 19, 2027 to stockholders of record on January 4, 2027. The 2027 Annual Meeting of shareholders will be held on January 29, 2027. The company completed the sale of VACCO Industries in Q4 2025, and VACCO results are presented as Discontinued Operations.
Disagree with this article?
Ctrl + Enter to submit